News

Hepatitis C testing and treatment in prisons is key to reducing infections, a new study by the Kirby Institute has shown. (SYDNEY, Friday 7 May 2021) A world-first Australian study has shown that broad access to hepatitis C testing and ...

A targeted vaccine strategy is critical in preventing infections and reducing deaths if supply does not allow for mass vaccination, a Kirby Institute study shows. (SYDNEY, Wednesday 5 May 2020) New research from UNSW’s Kirby Institute ...

With over 139 million COVID-19 cases globally, the latest challenge for medical researchers is a post-COVID-19 syndrome referred to as 'long COVID'. Since the COVID-19 global pandemic was declared over a year ago, medical research has ...

During the inaugural David Cooper Lecture, Dr Anthony Fauci shared fascinating insights into the HIV/AIDS epidemic in the 80s, the global response to COVID-19 and the politics of anti-vaxxers. Last night, thousands tuned in online to ...

Landmark investment will support researchers from the Kirby Institute to co-lead a major new cervical cancer elimination program The Kirby Institute at UNSW Sydney welcomes the announcement of an AU$8.1 million grant from the Minderoo ...

The Kirby Institute welcomes today’s launch of the NSW HIV Strategy 2021-2025 by NSW Health. The strategy sets out a series of targets and pathways towards achieving virtual elimination of HIV transmission in NSW, aiming to reduce ...

The World Health Organization (WHO) has released a new report that comprehensively addresses the prevention and control of the Human T-lymphotropic virus type 1 (HTLV-1) for the first time since this human retrovirus was discovered ...

Today, the Kirby Institute joins our colleagues and friends in mourning the loss and celebrating the life of Jude Byrne, a passionate advocate for the rights of people who use drugs in Australia and globally.  Jude was deeply involved ...

The Kirby Institute is pleased to announce that Bundjalung man Robert Monaghan has been appointed to the role of Manager – Aboriginal and Torres Strait Islander Research. The role was established at the end of 2020 as part of the Kirby ...

Despite recent declines in HIV among gay and bisexual men, genetic analysis shows that most of Australia’s transmission still occurs among this group. Like any virus, the movement of people from travel or migration helps HIV spread ...

The Kirby Institute joins the Papua New Guinea Institute of Medical Research (PNGIMR) and our colleagues and friends in Papua New Guinea (PNG) in mourning the loss of Dr Paison Dakulala, an internationally recognised leader in the ...

Australian scientists have described the evolution of immunity levels up to four months following COVID-19 infection, finding that while antibody levels drop dramatically in the first one to two months, the decrease then slows down ...

The Kirby Institute joins our colleagues in Zimbabwe in mourning the loss of Professor James Gita Hakim, a global leader in HIV treatment research and our close research collaborator and friend. He passed away due to complications from ...

On World Neglected Tropical Disease Day, researchers from the Kirby Institute highlight the progress made in NTD research in a year like no other. 2020 was a year in which the world came to understand how devastating an infectious ...

The Kirby Institute congratulates Dr Nicholas Medland, who has been named the next President of the Australasian Society for HIV, Viral Hepatitis and Sexual Health Medicine (ASHM). As clinical epidemiologist with the Kirby Institute’s ...

A team of leading Sydney researchers is pioneering the use of a fast genomic sequencing technology to help determine the source of hard-to-trace coronavirus cases. Thanks to cutting-edge ‘Nanopore’ genome sequencing technology, ...

There were 903 new HIV diagnoses in 2019. This represents a decline of 12 per cent over five years. While long term trends suggest HIV is declining in Australia, there was a slight increase in HIV numbers from 2018–2019.   The number ...

Professor Gregory Dore from the Kirby Institute at UNSW Sydney has won the prestigious 2020 Eureka Prize for Infectious Diseases Research. Professor Gregory Dore’s world-leading research on antiviral therapy for hepatitis C virus (HCV) ...